Identification of germline MSH2 gene mutations in endometrial cancer not fulfilling the new clinical criteria for hereditary nonpolyposis colorectal cancer

被引:25
作者
Banno, K
Susumu, N
Hirao, T
Yanokura, M
Hirasawa, A
Aoki, D
Udagawa, Y
Sugano, K
Nozawa, S
机构
[1] Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjyuku Ku, Tokyo 1608582, Japan
[2] Fujita Hlth Univ, Sch Med, Dept Obstet & Gynecol, Nagoya, Aichi, Japan
[3] Tochigi Canc Ctr, Res Inst, Oncogene Res Unit, Utsunomiya, Tochigi, Japan
关键词
D O I
10.1016/S0165-4608(03)00157-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Endometrial cancer is the second most common malignancy in patients with hereditary nonpolyposis colorectal cancer (HNPCC). This cancer is caused by germline mutations in one of the DNA mismatch repair (MMR) genes. The present study was undertaken to analyze the relation between microsatellite instability (MSI) and germline mutations of MMR genes. We analyzed MSI in 38 cases of endometrial cancer. MSI was present in one or more (out of 5 examined) regions in 11 (29%) cases. Furthermore, alterations in MLH1 and MSH2, two culprit genes representative of HNPCC, were examined in the 11 MSI-positive patients using polymerase chain reaction-single-strand conformation polymorphism and sequencing. Germline mutations, namely, 1) a missense mutation at codon 688 (ATG-->ATA, Met-->Ile) and 2) a missense mutation at codon 390 (CTT-->TTT, Leu-->Phe) of the MSH2 gene, were found in 2 of the 11 patients (18%). Although these two cases do not fulfill the new Amsterdam criteria, they had strong family histories of colorectal and endometrial carcinoma. Our results show that genetic testing is important in cases of endometrial cancer with a history suggestive of HNPCC even if the new Amsterdam criteria are not fulfilled. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:58 / 65
页数:8
相关论文
共 27 条
[1]  
Beck NE, 1997, BRIT J SURG, V84, P233, DOI 10.1002/bjs.1800840228
[2]   MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas [J].
Esteller, M ;
Levine, R ;
Baylin, SB ;
Ellenson, LH ;
Herman, JG .
ONCOGENE, 1998, 17 (18) :2413-2417
[3]  
Fink D, 1996, CANCER RES, V56, P4881
[4]  
Genuardi M, 1998, INT J CANCER, V75, P835, DOI 10.1002/(SICI)1097-0215(19980316)75:6<835::AID-IJC4>3.0.CO
[5]  
2-W
[6]  
HAN HJ, 1993, CANCER RES, V53, P5087
[7]  
Herfarth KKF, 1997, GENE CHROMOSOME CANC, V18, P42, DOI 10.1002/(SICI)1098-2264(199701)18:1<42::AID-GCC5>3.0.CO
[8]  
2-1
[9]  
HORII A, 1994, CANCER RES, V54, P3373
[10]   Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients [J].
Liu, B ;
Parsons, R ;
Papadopoulos, N ;
Nicolaides, NC ;
Lynch, HT ;
Watson, P ;
Jass, JR ;
Dunlop, M ;
Wyllie, A ;
Peltomaki, P ;
delaChapelle, A ;
Hamilton, SR ;
Vogelstein, B ;
Kinzler, KW .
NATURE MEDICINE, 1996, 2 (02) :169-174